The investment group Penta has denied media reports that it intends to sell private health-insurer Dôvera to the government, Penta spokesman Martin Danko said on May 9.
"We want to emphasise that Dôvera is not for sale, and we aren't holding any talks to that effect either with the state or with any private potential bidder," said Danko, as quoted by the TASR newswire. Danko stated that Penta has a long-term interest in the health-insurance sector and no sale is planned for the foreseeable future. Citing an unnamed source from within the investment group, the Hospodárske Noviny daily reported earlier on May 9 that the stance of Penta toward the sale of Dôvera had changed and that the government could buy the company for €400-450 million.
Compiled by Zuzana Vilikovská from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
10. May 2013 at 10:00